Bin Yang, CFA FRM, currently serves as a Technical Advisor at Brevan Howard since August 2022, and holds the position of Investor and Head of Business Development at OO Dental USA, also starting in October 2023. Additionally, Bin Yang is an Investor, COO, and Head of Business Development at Merdury Biopharmaceutical since August 2023, and functions as an Investor and Strategic Advisor at Sacurn Carbon starting in April 2024. As a Co-founder and CEO of AlgoTune since September 2021, and an Investor and Technical Advisor for givepact since May 2022, Bin Yang contributes to a crypto fundraising platform for nonprofits. Bin Yang also provides technical advice at Catalytic Capital Consortium, which supports impact-driven enterprises. Previous experience includes roles at YieldX as Co-Founder and Chief Research Officer, and at Franklin Templeton in various positions including Portfolio Manager and Senior Quantitative Researcher. Bin Yang holds a BCS in Computer Science from the University of Waterloo, earned between 2002 and 2007.
This person is not in the org chart
This person is not in any teams
This person is not in any offices